{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:32:36Z","timestamp":1772001156104,"version":"3.50.1"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T00:00:00Z","timestamp":1470960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T00:00:00Z","timestamp":1470960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00204-016-1810-z","type":"journal-article","created":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T13:39:11Z","timestamp":1471009151000},"page":"1833-1846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature"],"prefix":"10.1007","volume":"91","author":[{"given":"Thomas","family":"Efferth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Sch\u00f6ttler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Schmiedek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Wenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank A.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,12]]},"reference":[{"key":"1810_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00381-012-2013-4","volume":"29","author":"D Aguilera","year":"2013","unstructured":"Aguilera D, Mazewski C, Fangusaro J, MacDonald TJ, McNall-Knapp RY, Hayes LL, Kim S, Castellino RC (2013) Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience. Childs Nerv Syst 29:589\u2013596","journal-title":"Childs Nerv Syst"},{"key":"1810_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/jat.1734","volume":"33","author":"DD Alcantara","year":"2013","unstructured":"Alcantara DD, Ribeiro HF, Cardoso PC, Araujo TM, Burbano RR, Guimaraes AC, Khayat AS, de Oliveira Bahia M (2013) In vitro evaluation of the cytotoxic and genotoxic effects of artemether, an antimalarial drug, in a gastric cancer cell line (PG100). J Appl Toxicol 33:151\u2013156","journal-title":"J Appl Toxicol"},{"key":"1810_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11060-013-1303-3","volume":"116","author":"M Alonso-Basanta","year":"2014","unstructured":"Alonso-Basanta M, Fang P, Maity A, Hahn SM, Lustig RA, Dorsey JF (2014) A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme. J Neurooncol 116:365\u2013372","journal-title":"J Neurooncol"},{"key":"1810_CR4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.fct.2011.03.016","volume":"49","author":"I Aquino","year":"2011","unstructured":"Aquino I, Perazzo FF, Maistro EL (2011) Genotoxicity assessment of the antimalarial compound artesunate in somatic cells of mice. Food Chem Toxicol 49:1335\u20131339","journal-title":"Food Chem Toxicol"},{"key":"1810_CR5","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.4238\/2013.July.24.6","volume":"12","author":"I Aquino","year":"2013","unstructured":"Aquino I, Tsuboy MS, Marcarini JC, Mantovani MS, Perazzo FF, Maistro EL (2013) Genotoxic evaluation of the antimalarial drugs artemisinin and artesunate in human HepG2 cells and effects on CASP3 and SOD1 gene expressions. Genet Mol Res 12:2517\u20132527","journal-title":"Genet Mol Res"},{"key":"1810_CR6","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1215\/15228517-2008-120","volume":"11","author":"TS Armstrong","year":"2009","unstructured":"Armstrong TS, Cao Y, Scheurer ME, Vera-Bolanos E, Manning R, Okcu MF, Bondy M, Zhou R, Gilbert MR (2009) Risk analysis of severe myelotoxicity with temozolomide: the effects of clinical and genetic factors. Neuro Oncol 11:825\u2013832","journal-title":"Neuro Oncol"},{"key":"1810_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00066-013-0519-7","volume":"190","author":"F Becker","year":"2014","unstructured":"Becker F, Hecht M, Schmidtner J, Semrau S, Fietkau R (2014) Temozolomide-induced liver damage. A case report. Strahlenther Onkol 190:408\u2013410","journal-title":"Strahlenther Onkol"},{"key":"1810_CR8","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1080\/07357900802709159","volume":"27","author":"AY Bedikian","year":"2009","unstructured":"Bedikian AY, Papadopoulos NE, Kim KB, Hwu WJ, Homsi J, Glass MR, Cain S, Rudewicz P, Vernillet L, Hwu P (2009) A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanoma. Cancer Invest 27:756\u2013763","journal-title":"Cancer Invest"},{"key":"1810_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2174\/157489210791760526","volume":"5","author":"R Bei","year":"2010","unstructured":"Bei R, Marzocchella L, Turriziani M (2010) The use of temozolomide for the treatment of malignant tumors: clinical evidence and molecular mechanisms of action. Recent Pat Anticancer Drug Discov 5:172\u2013187","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"1810_CR10","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1158\/1535-7163.MCT-11-0534","volume":"10","author":"N Berdelle","year":"2011","unstructured":"Berdelle N, Nikolova T, Quiros S, Efferth T, Kaina B (2011) Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM\/ATR damage response in cancer cells. Mol Cancer Ther 10:2224\u20132233","journal-title":"Mol Cancer Ther"},{"key":"1810_CR11","first-page":"1599","volume":"14","author":"TG Berger","year":"2005","unstructured":"Berger TG, Dieckmann D, Efferth T, Schultz ES, Funk JO, Baur A, Schuler G (2005) Artesunate in the treatment of metastatic uveal melanoma\u2013first experiences. Oncol Rep 14:1599\u20131603","journal-title":"Oncol Rep"},{"key":"1810_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2217\/cns.14.50","volume":"4","author":"AS Berghoff","year":"2015","unstructured":"Berghoff AS, Hainfellner JA, Marosi C, Preusser M (2015) Assessing MGMT methylation status and its current impact on treatment in glioblastoma. CNS Oncol 4:47\u201352","journal-title":"CNS Oncol"},{"key":"1810_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s13659-014-0013-7","volume":"4","author":"E Breuer","year":"2014","unstructured":"Breuer E, Efferth T (2014) Treatment of iron-loaded veterinary sarcoma by artemisia annua. Nat Prod Bioprospect 4:113\u2013118","journal-title":"Nat Prod Bioprospect"},{"key":"1810_CR14","first-page":"752","volume":"69","author":"L Cao","year":"2014","unstructured":"Cao L, Duanmu W, Yin Y, Zhou Z, Ge H, Chen T, Tan L, Yu A, Hu R, Fei L, Feng H (2014) Dihydroartemisinin exhibits anti-glioma stem cell activity through inhibiting p-AKT and activating caspase-3. Pharmazie 69:752\u2013758","journal-title":"Pharmazie"},{"key":"1810_CR15","first-page":"854","volume":"58","author":"CDC","year":"2009","unstructured":"CDC (2009) Hepatitis temporally associated with an herbal supplement containing artemisinin, Washington, 2008. Centers for disease control and_ prevention. MMWR Morb Mortal Wkly Rep 58:854\u2013856","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1810_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10072-014-1963-6","volume":"36","author":"J Chen","year":"2015","unstructured":"Chen J, Chen X, Wang F, Gao H, Hu W (2015) Dihydroartemisinin suppresses glioma proliferation and invasion via inhibition of the ADAM17 pathway. Neurol Sci 36:435\u2013440","journal-title":"Neurol Sci"},{"key":"1810_CR17","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1212\/01.wnl.0000259430.48835.b5","volume":"68","author":"MG Chheda","year":"2007","unstructured":"Chheda MG, Drappatz J, Greenberger NJ, Kesari S, Weiss SE, Gigas DC, Doherty LM, Wen PY (2007) Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note. Neurology 68:955\u2013956","journal-title":"Neurology"},{"key":"1810_CR18","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jep.2013.07.008","volume":"149","author":"YY Choi","year":"2013","unstructured":"Choi YY, Kim MH, Cho IH, Kim JH, Hong J, Lee TH, Yang WM (2013) Inhibitory effect of Coptis chinensis on inflammation in LPS-induced endotoxemia. J Ethnopharmacol 149:506\u2013512","journal-title":"J Ethnopharmacol"},{"key":"1810_CR19","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1200\/JCO.2008.20.7944","volume":"27","author":"JL Clarke","year":"2009","unstructured":"Clarke JL, Iwamoto FM, Sul J, Panageas K, Lassman AB, DeAngelis LM, Hormigo A, Nolan CP, Gavrilovic I, Karimi S, Abrey LE (2009) Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma. J Clin Oncol 27:3861\u20133867","journal-title":"J Clin Oncol"},{"key":"1810_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jcv.2009.05.011","volume":"46","author":"JR Crawford","year":"2009","unstructured":"Crawford JR, Santi MR, Thorarinsdottir HK, Cornelison R, Rushing EJ, Zhang H, Yao K, Jacobson S, Macdonald TJ (2009) Detection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomas. J Clin Virol 46:37\u201342","journal-title":"J Clin Virol"},{"key":"1810_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/sj.bjc.6600717","volume":"88","author":"GC de Gast","year":"2003","unstructured":"de Gast GC, Batchelor D, Kersten MJ, Vyth-Dreese FA, Sein J, van de Kasteele WF, Nooijen WJ, Nieweg OE, de Waal MA, Boogerd W (2003) Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanoma. Br J Cancer 88:175\u2013180","journal-title":"Br J Cancer"},{"key":"1810_CR22","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1046\/j.1365-3156.1997.d01-155.x","volume":"2","author":"PJ de Vries","year":"1997","unstructured":"de Vries PJ, Nguyen XK, Tran KD, Le Nguyen B, Nguyen TY, Dao DD, van Boxtel CJ, Kager PA (1997) The pharmacokinetics of a single dose of artemisinin in subjects with liver cirrhosis. Bach Mai-Amsterdam Research Group on Artemisinin. Trop Med Int Health 2:957\u2013962","journal-title":"Trop Med Int Health"},{"key":"1810_CR23","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/j.bcp.2004.08.021","volume":"68","author":"R Dell\u2019Eva","year":"2004","unstructured":"Dell\u2019Eva R, Pfeffer U, Vene R, Anfosso L, Forlani A, Albini A, Efferth T (2004) Inhibition of angiogenesis in vivo and growth of Kaposi\u2019s sarcoma xenograft tumors by the anti-malarial artesunate. Biochem Pharmacol 68:2359\u20132366","journal-title":"Biochem Pharmacol"},{"key":"1810_CR24","doi-asserted-by":"publisher","first-page":"10854","DOI":"10.1158\/0008-5472.CAN-05-1216","volume":"65","author":"GL Disbrow","year":"2005","unstructured":"Disbrow GL, Baege AC, Kierpiec KA, Yuan H, Centeno JA, Thibodeaux CA, Hartmann D, Schlegel R (2005) Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo. Cancer Res 65:10854\u201310861","journal-title":"Cancer Res"},{"key":"1810_CR25","first-page":"249","volume":"111","author":"S Dixit","year":"2011","unstructured":"Dixit S, Hingorani M, Afzal P, Campbell AP (2011) Temozolomide induced liver injury. Acta Neurol Belg 111:249\u2013251","journal-title":"Acta Neurol Belg"},{"key":"1810_CR26","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00280-009-1095-5","volume":"65","author":"JH Du","year":"2010","unstructured":"Du JH, Zhang HD, Ma ZJ, Ji KM (2010) Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo. Cancer Chemother Pharmacol 65:895\u2013902","journal-title":"Cancer Chemother Pharmacol"},{"key":"1810_CR27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/neuonc\/nor227","volume":"14","author":"K Dziurzynski","year":"2012","unstructured":"Dziurzynski K, Chang SM, Heimberger AB, Kalejta RF, McGregor Dallas SR, Smit M, Soroceanu L, Cobbs CS (2012) Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol 14:246\u2013255","journal-title":"Neuro Oncol"},{"key":"1810_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.15806\/j.issn.2311-8571.2015.0036","volume":"1","author":"T Efferth","year":"2015","unstructured":"Efferth T (2015) Artemisinin\u2014second career as anticancer drug? World J Trad Chen Med 1:2\u201325","journal-title":"World J Trad Chen Med"},{"key":"1810_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3109\/10408441003610571","volume":"40","author":"T Efferth","year":"2010","unstructured":"Efferth T, Kaina B (2010) Toxicity of the antimalarial artemisinin and its derivatives. Crit Rev Toxicol 40:405\u2013421","journal-title":"Crit Rev Toxicol"},{"key":"1810_CR30","first-page":"196","volume":"46","author":"T Efferth","year":"1996","unstructured":"Efferth T, R\u00fccker G, Falkenberg M, Manns D, Olbrich A, Fabry U, Osieka R (1996) Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs. Arzneimittelforschung 46:196\u2013200","journal-title":"Arzneimittelforschung"},{"key":"1810_CR31","first-page":"767","volume":"18","author":"T Efferth","year":"2001","unstructured":"Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR (2001) The anti-malarial artesunate is also active against cancer. Int J Oncol 18:767\u2013773","journal-title":"Int J Oncol"},{"key":"1810_CR32","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0006-2952(02)01221-2","volume":"64","author":"T Efferth","year":"2002","unstructured":"Efferth T, Olbrich A, Bauer R (2002) mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether. Biochem Pharmacol 64:617\u2013623","journal-title":"Biochem Pharmacol"},{"key":"1810_CR33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1124\/mol.64.2.382","volume":"64","author":"T Efferth","year":"2003","unstructured":"Efferth T, Sauerbrey A, Olbrich A, Gebhart E, Rauch P, Weber HO, Hengstler JG, Halatsch ME, Volm M, Tew KD, Ross DD, Funk JO (2003) Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol 64:382\u2013394","journal-title":"Mol Pharmacol"},{"key":"1810_CR34","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.freeradbiomed.2004.06.023","volume":"37","author":"T Efferth","year":"2004","unstructured":"Efferth T, Benakis A, Romero MR, Tomicic M, Rauh R, Steinbach D, Hafer R, Stamminger T, Oesch F, Kaina B, Marschall M (2004a) Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radic Biol Med 37:998\u20131009","journal-title":"Free Radic Biol Med"},{"key":"1810_CR35","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.bcp.2003.12.035","volume":"67","author":"T Efferth","year":"2004","unstructured":"Efferth T, Ramirez T, Gebhart E, Halatsch ME (2004b) Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774. Biochem Pharmacol 67:1689\u20131700","journal-title":"Biochem Pharmacol"},{"key":"1810_CR36","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s00228-014-1754-2","volume":"70","author":"T Ericsson","year":"2014","unstructured":"Ericsson T, Blank A, von Hagens C, Ashton M, Abelo A (2014a) Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer. Eur J Clin Pharmacol 70:1453\u20131463","journal-title":"Eur J Clin Pharmacol"},{"key":"1810_CR37","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3109\/00498254.2013.878815","volume":"44","author":"T Ericsson","year":"2014","unstructured":"Ericsson T, Sundell J, Torkelsson A, Hoffmann KJ, Ashton M (2014b) Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies. Xenobiotica 44:615\u2013626","journal-title":"Xenobiotica"},{"key":"1810_CR38","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s10147-011-0294-3","volume":"17","author":"Y Fujimoto","year":"2012","unstructured":"Fujimoto Y, Hashimoto N, Kinoshita M, Miyazaki Y, Tanaka S, Yakushijin T, Takehara T, Kagawa N, Yoshimine T (2012) Hepatitis B virus reactivation associated with temozolomide for malignant glioma: a case report and recommendation for prophylaxis. Int J Clin Oncol 17:290\u2013293","journal-title":"Int J Clin Oncol"},{"key":"1810_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/01.cmr.0000215042.53683.40","volume":"16","author":"M Garcia","year":"2006","unstructured":"Garcia M, del Muro XG, Tres A, Crespo C, Valladares M, Lopez JJ, Rifa J, Perez X, Filipovich E, Germa-Lluch JR (2006) Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma. Melanoma Res 16:365\u2013370","journal-title":"Melanoma Res"},{"key":"1810_CR40","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1086\/511882","volume":"44","author":"P German","year":"2007","unstructured":"German P, Greenhouse B, Coates C, Dorsey G, Rosenthal PJ, Charlebois E, Lindegardh N, Havlir D, Aweeka FT (2007) Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz. Clin Infect Dis 44:889\u2013891","journal-title":"Clin Infect Dis"},{"key":"1810_CR41","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1517\/14656566.9.2.285","volume":"9","author":"T Gerstner","year":"2008","unstructured":"Gerstner T, Bell N, Konig S (2008) Oral valproic acid for epilepsy\u2013long-term experience in therapy and side effects. Expert Opin Pharmacother 9:285\u2013292","journal-title":"Expert Opin Pharmacother"},{"key":"1810_CR42","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/0306-3623(93)90434-Y","volume":"24","author":"AH Gilani","year":"1993","unstructured":"Gilani AH, Janbaz KH (1993) Protective effect of Artemisia scoparia extract against acetaminophen-induced hepatotoxicity. Gen Pharmacol 24:1455\u20131458","journal-title":"Gen Pharmacol"},{"key":"1810_CR43","first-page":"65","volume":"44","author":"AH Gilani","year":"1994","unstructured":"Gilani AH, Janbaz KH (1994) Hepatoprotective effects of artemisia scoparia against carbon tetrachloride: an environmental contaminant. J Pak Med Assoc 44:65\u201368","journal-title":"J Pak Med Assoc"},{"key":"1810_CR44","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1186\/1471-2407-14-992","volume":"14","author":"FA Giordano","year":"2014","unstructured":"Giordano FA, Brehmer S, Abo-Madyan Y, Welzel G, Sperk E, Keller A, Schneider F, Clausen S, Herskind C, Schmiedek P, Wenz F (2014) INTRAGO: intraoperative radiotherapy in glioblastoma multiforme-a phase I\/II dose escalation study. BMC Cancer 14:992","journal-title":"BMC Cancer"},{"key":"1810_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11060-010-0354-y","volume":"103","author":"A Goldbecker","year":"2011","unstructured":"Goldbecker A, Tryc AB, Raab P, Worthmann H, Herrmann J, Weissenborn K (2011) Hepatic encephalopathy after treatment with temozolomide. J Neurooncol 103:163\u2013166","journal-title":"J Neurooncol"},{"key":"1810_CR46","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s10620-012-2493-9","volume":"58","author":"LM Grant","year":"2013","unstructured":"Grant LM, Kleiner DE, Conjeevaram HS, Vuppalanchi R, Lee WM (2013) Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide. Dig Dis Sci 58:1415\u20131421","journal-title":"Dig Dis Sci"},{"key":"1810_CR47","doi-asserted-by":"publisher","first-page":"e476","DOI":"10.1097\/MD.0000000000000476","volume":"94","author":"A Grieco","year":"2015","unstructured":"Grieco A, Tafuri MA, Biolato M, Diletto B, Di Napoli N, Balducci N, Vecchio FM, Miele L (2015) Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literature. Medicine (Baltimore) 94:e476","journal-title":"Medicine (Baltimore)"},{"key":"1810_CR48","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1211\/jpp.59.6.0011","volume":"59","author":"XJ Huang","year":"2007","unstructured":"Huang XJ, Ma ZQ, Zhang WP, Lu YB, Wei EQ (2007) Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1alpha activation in C6 glioma cells. J Pharm Pharmacol 59:849\u2013856","journal-title":"J Pharm Pharmacol"},{"key":"1810_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000125673","volume":"82","author":"XJ Huang","year":"2008","unstructured":"Huang XJ, Li CT, Zhang WP, Lu YB, Fang SH, Wei EQ (2008) Dihydroartemisinin potentiates the cytotoxic effect of temozolomide in rat C6 glioma cells. Pharmacology 82:1\u20139","journal-title":"Pharmacology"},{"key":"1810_CR50","first-page":"4417","volume":"31","author":"FH Jansen","year":"2011","unstructured":"Jansen FH, Adoubi I, JC KC, De Cnodder T, Jansen N, Tschulakow A, Efferth T (2011) First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers. Anticancer Res 31:4417\u20134422","journal-title":"Anticancer Res"},{"key":"1810_CR51","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2174\/18715206113136660340","volume":"14","author":"G Karpel-Massler","year":"2014","unstructured":"Karpel-Massler G, Westhoff MA, Kast RE, Dwucet A, Nonnenmacher L, Wirtz CR, Debatin KM, Halatsch ME (2014) Artesunate enhances the antiproliferative effect of temozolomide on U87MG and A172 glioblastoma cell lines. Anticancer Agents Med Chem 14:313\u2013318","journal-title":"Anticancer Agents Med Chem"},{"key":"1810_CR52","doi-asserted-by":"publisher","first-page":"502","DOI":"10.18632\/oncotarget.969","volume":"4","author":"RE Kast","year":"2013","unstructured":"Kast RE, Boockvar JA, Bruning A, Cappello F, Chang WW, Cvek B, Dou QP, Duenas-Gonzalez A, Efferth T, Focosi D, Ghaffari SH, Karpel-Massler G, Ketola K, Khoshnevisan A, Keizman D, Magne N, Marosi C, McDonald K, Munoz M, Paranjpe A, Pourgholami MH, Sardi I, Sella A, Srivenugopal KS, Tuccori M, Wang W, Wirtz CR, Halatsch ME (2013) A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care. Oncotarget 4:502\u2013530","journal-title":"Oncotarget"},{"key":"1810_CR53","doi-asserted-by":"publisher","first-page":"8052","DOI":"10.18632\/oncotarget.2408","volume":"5","author":"RE Kast","year":"2014","unstructured":"Kast RE, Karpel-Massler G, Halatsch ME (2014) CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide. Oncotarget 5:8052\u20138082","journal-title":"Oncotarget"},{"key":"1810_CR54","doi-asserted-by":"publisher","first-page":"e798","DOI":"10.1371\/journal.pone.0000798","volume":"2","author":"G Kelter","year":"2007","unstructured":"Kelter G, Steinbach D, Konkimalla VB, Tahara T, Taketani S, Fiebig HH, Efferth T (2007) Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate. PLoS ONE 2:e798","journal-title":"PLoS ONE"},{"key":"1810_CR55","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00432-005-0052-x","volume":"132","author":"SJ Kim","year":"2006","unstructured":"Kim SJ, Kim MS, Lee JW, Lee CH, Yoo H, Shin SH, Park MJ, Lee SH (2006) Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro. J Cancer Res Clin Oncol 132:129\u2013135","journal-title":"J Cancer Res Clin Oncol"},{"key":"1810_CR56","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/neuonc\/nop030","volume":"12","author":"DS Kong","year":"2010","unstructured":"Kong DS, Lee JI, Kim JH, Kim ST, Kim WS, Suh YL, Dong SM, Nam DH (2010) Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma. Neuro Oncol 12:289\u2013296","journal-title":"Neuro Oncol"},{"key":"1810_CR57","first-page":"361","volume":"30","author":"JR Kouvaris","year":"2007","unstructured":"Kouvaris JR, Miliadou A, Kouloulias VE, Kolokouris D, Balafouta MJ, Papacharalampous XN, Vlahos LJ (2007) Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors. Onkologie 30:361\u2013366","journal-title":"Onkologie"},{"key":"1810_CR58","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ebiom.2014.11.010","volume":"2","author":"S Krishna","year":"2015","unstructured":"Krishna S, Ganapathi S, Ster IC, Saeed ME, Cowan M, Finlayson C, Kovacsevics H, Jansen H, Kremsner PG, Efferth T, Kumar D (2015) A randomised, double blind, placebo-controlled pilot study of oral artesunate therapy for colorectal cancer. EBioMedicine 2:82\u201390","journal-title":"EBioMedicine"},{"key":"1810_CR59","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.phymed.2013.08.018","volume":"21","author":"V Kuete","year":"2014","unstructured":"Kuete V, Sandjo LP, Ouete JL, Fouotsa H, Wiench B, Efferth T (2014) Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines. Phytomedicine 21:315\u2013322","journal-title":"Phytomedicine"},{"key":"1810_CR60","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.phymed.2015.07.006","volume":"22","author":"V Kuete","year":"2015","unstructured":"Kuete V, Mbaveng AT, Zeino M, Fozing CD, Ngameni B, Kapche GD, Ngadjui BT, Efferth T (2015) Cytotoxicity of three naturally occurring flavonoid derived compounds (artocarpesin, cycloartocarpesin and isobavachalcone) towards multi-factorial drug-resistant cancer cells. Phytomedicine 22:1096\u20131102","journal-title":"Phytomedicine"},{"key":"1810_CR61","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/hep.27900","volume":"62","author":"S Kumar","year":"2015","unstructured":"Kumar S (2015) Cholestatic liver injury secondary to artemisinin. Hepatology 62:973\u2013974","journal-title":"Hepatology"},{"key":"1810_CR62","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.canlet.2005.01.019","volume":"231","author":"H Lai","year":"2006","unstructured":"Lai H, Singh NP (2006) Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat. Cancer Lett 231:43\u201348","journal-title":"Cancer Lett"},{"key":"1810_CR63","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.fct.2015.06.004","volume":"84","author":"WJ Lee","year":"2015","unstructured":"Lee WJ, Kim HW, Lee HY, Son CG (2015) Systematic review on herb-induced liver injury in Korea. Food Chem Toxicol 84:47\u201354","journal-title":"Food Chem Toxicol"},{"key":"1810_CR64","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.mehy.2009.07.005","volume":"74","author":"S Lehrer","year":"2010","unstructured":"Lehrer S (2010) Anopheles mosquito transmission of brain tumor. Med Hypotheses 74:167\u2013168","journal-title":"Med Hypotheses"},{"key":"1810_CR65","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/ijc.22804","volume":"121","author":"LN Li","year":"2007","unstructured":"Li LN, Zhang HD, Yuan SJ, Tian ZY, Wang L, Sun ZX (2007) Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt\/beta-catenin pathway. Int J Cancer 121:1360\u20131365","journal-title":"Int J Cancer"},{"key":"1810_CR66","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1158\/0008-5472.CAN-07-2970","volume":"68","author":"PC Li","year":"2008","unstructured":"Li PC, Lam E, Roos WP, Zdzienicka MZ, Kaina B, Efferth T (2008) Artesunate derived from traditional Chinese medicine induces DNA damage and repair. Cancer Res 68:4347\u20134351","journal-title":"Cancer Res"},{"key":"1810_CR67","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/COC.0b013e3182a790ea","volume":"38","author":"G Lombardi","year":"2015","unstructured":"Lombardi G, Rumiato E, Bertorelle R, Saggioro D, Farina P, Della Puppa A, Zustovich F, Berti F, Sacchetto V, Marcato R, Amadori A, Zagonel V (2015) Clinical and genetic factors associated with severe hematological toxicity in glioblastoma patients during radiation plus temozolomide treatment: a prospective study. Am J Clin Oncol 38:514\u2013519","journal-title":"Am J Clin Oncol"},{"key":"1810_CR68","doi-asserted-by":"publisher","first-page":"10556","DOI":"10.3390\/molecules161210556","volume":"16","author":"H Ma","year":"2011","unstructured":"Ma H, Yao Q, Zhang AM, Lin S, Wang XX, Wu L, Sun JG, Chen ZT (2011) The effects of artesunate on the expression of EGFR and ABCG2 in A549 human lung cancer cells and a xenograft model. Molecules 16:10556\u201310569","journal-title":"Molecules"},{"key":"1810_CR69","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1097\/MPH.0b013e3181e51403","volume":"32","author":"JR Madden","year":"2010","unstructured":"Madden JR, Addo-Yobo SO, Donson AM, Liu AK, McNatt SA, Kleinschmidt-Demasters BK, Fenton LZ, Foreman NK, Smith AA (2010) Radiation-induced glioblastoma multiforme in children treated for medulloblastoma with characteristics of both medulloblastoma and glioblastoma multiforme. J Pediatr Hematol Oncol 32:e272\u2013e278","journal-title":"J Pediatr Hematol Oncol"},{"key":"1810_CR70","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.phrs.2007.08.003","volume":"56","author":"F Marchesi","year":"2007","unstructured":"Marchesi F, Turriziani M, Tortorelli G, Avvisati G, Torino F, De Vecchis L (2007) Triazene compounds: mechanism of action and related DNA repair systems. Pharmacol Res 56:275\u2013287","journal-title":"Pharmacol Res"},{"key":"1810_CR71","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1472-6882-14-115","volume":"14","author":"T Melchardt","year":"2014","unstructured":"Melchardt T, Magnes T, Weiss L, Grundbichler M, Strasser M, Hufnagl C, Moik M, Greil R, Egle A (2014) Liver toxicity during temozolomide chemotherapy caused by Chinese herbs. BMC Complement Altern Med 14:115","journal-title":"BMC Complement Altern Med"},{"key":"1810_CR72","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.phymed.2015.11.001","volume":"22","author":"F Michaelsen","year":"2015","unstructured":"Michaelsen F, Saeed M, Schwarzkopf J, Efferth T (2015) Activity of Artemisia annua and artemisinin derivatives in prostate carcinoma. Phytomedicine 22:1223\u20131231","journal-title":"Phytomedicine"},{"key":"1810_CR73","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1017\/S0317167100018187","volume":"39","author":"RJ Miller","year":"2012","unstructured":"Miller RJ, Gui X, Easaw JC, Tsang RY (2012) Chemotherapy-associated steatohepatitis with temozolomide and dexamethasone. Can J Neurol Sci 39:547\u2013549","journal-title":"Can J Neurol Sci"},{"key":"1810_CR74","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0304-3835(06)80014-5","volume":"98","author":"JC Moore","year":"1995","unstructured":"Moore JC, Lai H, Li JR, Ren RL, McDougall JA, Singh NP, Chou CK (1995) Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat. Cancer Lett 98:83\u201387","journal-title":"Cancer Lett"},{"key":"1810_CR75","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.1128\/AAC.02716-14","volume":"58","author":"CA Morris","year":"2014","unstructured":"Morris CA, Pokorny R, Lopez-Lazaro L, Miller RM, Arbe-Barnes S, Duparc S, Borghini-Fuhrer I, Shin JS, Fleckenstein L (2014) Pharmacokinetic interaction between pyronaridine-artesunate and metoprolol. Antimicrob Agents Chemother 58:5900\u20135908","journal-title":"Antimicrob Agents Chemother"},{"key":"1810_CR76","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.nec.2012.01.007","volume":"23","author":"DT Nagasawa","year":"2012","unstructured":"Nagasawa DT, Chow F, Yew A, Kim W, Cremer N, Yang I (2012) Temozolomide and other potential agents for the treatment of glioblastoma multiforme. Neurosurg Clin N Am 23:307\u2013322","journal-title":"Neurosurg Clin N Am"},{"key":"1810_CR77","first-page":"131","volume":"108","author":"B Neyns","year":"2008","unstructured":"Neyns B, Hoorens A, Stupp R (2008) Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide. Acta Neurol Belg 108:131\u2013134","journal-title":"Acta Neurol Belg"},{"key":"1810_CR78","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/1748-717X-6-141","volume":"6","author":"M Niewald","year":"2011","unstructured":"Niewald M, Berdel C, Fleckenstein J, Licht N, Ketter R, Rube C (2011) Toxicity after radiochemotherapy for glioblastoma using temozolomide\u2013a retrospective evaluation. Radiat Oncol 6:141","journal-title":"Radiat Oncol"},{"key":"1810_CR79","doi-asserted-by":"publisher","first-page":"728","DOI":"10.2176\/nmc.51.728","volume":"51","author":"M Ohno","year":"2011","unstructured":"Ohno M, Narita Y, Miyakita Y, Ueno H, Kayama T, Shibui S (2011) Reactivation of hepatitis B virus after glioblastoma treatment with temozolomide\u2013case report. Neurol Med Chir (Tokyo) 51:728\u2013731","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1810_CR80","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/S2352-3026(15)00074-5","volume":"2","author":"A Omuro","year":"2015","unstructured":"Omuro A, Chinot O, Taillandier L, Ghesquieres H, Soussain C, Delwail V, Lamy T, Gressin R, Choquet S, Soubeyran P, Huchet A, Benouaich-Amiel A, Lebouvier-Sadot S, Gyan E, Touitou V, Barrie M, Del Rio MS, Gonzalez-Aguilar A, Houillier C, Delgadillo D, Lacomblez L, Tanguy ML, Hoang-Xuan K (2015) Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial. Lancet Haematol 2:e251\u2013e259","journal-title":"Lancet Haematol"},{"key":"1810_CR81","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.phymed.2015.08.002","volume":"22","author":"E Ooko","year":"2015","unstructured":"Ooko E, Saeed ME, Kadioglu O, Sarvi S, Colak M, Elmasaoudi K, Janah R, Greten HJ, Efferth T (2015) Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells. Phytomedicine 22:1045\u20131054","journal-title":"Phytomedicine"},{"key":"1810_CR82","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS (2014) The epidemiology of glioma in adults: a \u201cstate of the science\u201d review. Neuro Oncol 16:896\u2013913","journal-title":"Neuro Oncol"},{"key":"1810_CR83","first-page":"1339","volume":"35","author":"J Park","year":"2015","unstructured":"Park J, Lai HC, Sasaki T, Singh NP (2015) DNA damage in dihydroartemisinin-resistant Molt-4 cells. Anticancer Res 35:1339\u20131343","journal-title":"Anticancer Res"},{"key":"1810_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11523-015-0378-5","volume":"11","author":"F Pistollato","year":"2016","unstructured":"Pistollato F, Bremer-Hoffmann S, Basso G, Cano SS, Elio I, Vergara MM, Giampieri F, Battino M (2016) Targeting glioblastoma with the use of phytocompounds and nanoparticles. Target Oncol 11:1\u201316","journal-title":"Target Oncol"},{"key":"1810_CR85","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00280-011-1721-x","volume":"69","author":"J Portnow","year":"2012","unstructured":"Portnow J, Frankel P, Koehler S, Twardowski P, Shibata S, Martel C, Morgan R, Cristea M, Chow W, Lim D, Chung V, Reckamp K, Leong L, Synold TW (2012) A phase I study of bortezomib and temozolomide in patients with advanced solid tumors. Cancer Chemother Pharmacol 69:505\u2013514","journal-title":"Cancer Chemother Pharmacol"},{"key":"1810_CR86","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00280-007-0556-y","volume":"61","author":"MD Prados","year":"2008","unstructured":"Prados MD, Yung WK, Wen PY, Junck L, Cloughesy T, Fink K, Chang S, Robins HI, Dancey J, Kuhn J (2008) Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study. Cancer Chemother Pharmacol 61:1059\u20131067","journal-title":"Cancer Chemother Pharmacol"},{"key":"1810_CR87","first-page":"214","volume":"23","author":"Prescrire International","year":"2014","unstructured":"Prescrire International (2014) Temozolomide: fatal hepatic failure. Prescr Int 23:214","journal-title":"Prescr Int"},{"key":"1810_CR88","first-page":"3629","volume":"18","author":"F Purchiaroni","year":"2014","unstructured":"Purchiaroni F, Begini P, Minniti G, Gallina S, Delle Fave G, Marignani M (2014) Glioblastoma multiforme and hepatitis B: do the right thing(s). Eur Rev Med Pharmacol Sci 18:3629\u20133631","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1810_CR89","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.radonc.2012.03.018","volume":"103","author":"S Reichert","year":"2012","unstructured":"Reichert S, Reinboldt V, Hehlgans S, Efferth T, Rodel C, Rodel F (2012) A radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein survivin. Radiother Oncol 103:394\u2013401","journal-title":"Radiother Oncol"},{"key":"1810_CR90","first-page":"50","volume":"58","author":"IR Ribeiro","year":"1998","unstructured":"Ribeiro IR, Olliaro P (1998) Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials. Med Trop (Mars) 58:50\u201353","journal-title":"Med Trop (Mars)"},{"key":"1810_CR91","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1365-2133.2004.06019.x","volume":"151","author":"E Richtig","year":"2004","unstructured":"Richtig E, Hofmann-Wellenhof R, Pehamberger H, Forstinger C, Wolff K, Mischer P, Raml J, Fritsch P, Zelger B, Ratzinger G, Koller J, Lang A, Konrad K, Kindermann-Glebowski E, Seeber A, Steiner A, Fialla R, Pachinger W, Kos C, Klein G, Kehrer H, Kerl H, Ulmer H, Smolle J (2004) Temozolomide and interferon alpha 2b in metastatic melanoma stage IV. Br J Dermatol 151:91\u201398","journal-title":"Br J Dermatol"},{"key":"1810_CR92","first-page":"1819","volume":"33","author":"GR Rutteman","year":"2013","unstructured":"Rutteman GR, Erich SA, Mol JA, Spee B, Grinwis GC, Fleckenstein L, London CA, Efferth T (2013) Safety and efficacy field study of artesunate for dogs with non-resectable tumours. Anticancer Res 33:1819\u20131827","journal-title":"Anticancer Res"},{"key":"1810_CR93","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/neuonc\/nos056","volume":"14","author":"G Sarganas","year":"2012","unstructured":"Sarganas G, Orzechowski HD, Klimpel A, Thomae M, Kauffmann W, Herbst H, Bronder E, Garbe E (2012) Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system. Neuro Oncol 14:541\u2013546","journal-title":"Neuro Oncol"},{"key":"1810_CR94","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2298\/AOO0204279S","volume":"10","author":"NP Singh","year":"2002","unstructured":"Singh NP, Verma KB (2002) Case report of a laryngeal squamous cell carcinoma treated with artesunate. Arch Oncol 10:279\u2013280","journal-title":"Arch Oncol"},{"key":"1810_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrgentox.2014.11.001","volume":"777","author":"S Singh","year":"2015","unstructured":"Singh S, Giri A, Giri S (2015) The antimalarial agent artesunate causes sperm DNA damage and hepatic antioxidant defense in mice. Mutat Res, Genet Toxicol Environ Mutagen 777:1\u20136","journal-title":"Mutat Res, Genet Toxicol Environ Mutagen"},{"key":"1810_CR96","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/1475-2875-8-200","volume":"8","author":"K Stepniewska","year":"2009","unstructured":"Stepniewska K, Taylor W, Sirima SB, Ouedraogo EB, Ouedraogo A, Gansane A, Simpson JA, Morgan CC, White NJ, Kiechel JR (2009) Population pharmacokinetics of artesunate and amodiaquine in African children. Malar J 8:200","journal-title":"Malar J"},{"key":"1810_CR97","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"key":"1810_CR98","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5\u00a0year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459\u2013466","journal-title":"Lancet Oncol"},{"key":"1810_CR99","doi-asserted-by":"publisher","first-page":"471","DOI":"10.5414\/CP202282","volume":"53","author":"JS Sunwoo","year":"2015","unstructured":"Sunwoo JS, Byun JI, Lee SK (2015) A case of lacosamide-induced hepatotoxicity. Int J Clin Pharmacol Ther 53:471\u2013473","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1810_CR100","doi-asserted-by":"publisher","first-page":"498","DOI":"10.7326\/M15-0910","volume":"163","author":"PS Twomey","year":"2015","unstructured":"Twomey PS, Smith BL, McDermott C, Novitt-Moreno A, McCarthy W, Kachur SP, Arguin PM (2015) Intravenous artesunate for the treatment of severe and complicated malaria in the United States: clinical use under an investigational new drug protocol. Ann Intern Med 163:498\u2013506","journal-title":"Ann Intern Med"},{"key":"1810_CR101","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/pbc.22407","volume":"54","author":"LM Wagner","year":"2010","unstructured":"Wagner LM, Perentesis JP, Reid JM, Ames MM, Safgren SL, Nelson MD Jr, Ingle AM, Blaney SM, Adamson PC (2010) Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children\u2019s Oncology Group phase I consortium study. Pediatr Blood Cancer 54:538\u2013545","journal-title":"Pediatr Blood Cancer"},{"key":"1810_CR102","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4103\/0028-3886.115065","volume":"61","author":"Y Wang","year":"2013","unstructured":"Wang Y, Liu B, Xu D, Zhao H, Zhu Y, Xu J, Tao R (2013a) Phase II trial of temozolomide plus concurrent whole-brain radiation followed by TNV regimen as adjuvant therapy for patients with newly diagnosed primary CNS lymphoma. Neurol India 61:260\u2013264","journal-title":"Neurol India"},{"key":"1810_CR103","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.metabol.2013.03.004","volume":"62","author":"ZQ Wang","year":"2013","unstructured":"Wang ZQ, Zhang XH, Yu Y, Tipton RC, Raskin I, Ribnicky D, Johnson W, Cefalu WT (2013b) Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway. Metabolism 62:1239\u20131249","journal-title":"Metabolism"},{"key":"1810_CR104","first-page":"17102","volume":"8","author":"W Wang","year":"2015","unstructured":"Wang W, Liu F, Xiang B, Xiang C, Mou X (2015) Stem cells as cellular vehicles for gene therapy against glioblastoma. Int J Clin Exp Med 8:17102\u201317109","journal-title":"Int J Clin Exp Med"},{"key":"1810_CR105","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S1470-2045(12)70164-X","volume":"13","author":"W Wick","year":"2012","unstructured":"Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, Combs SE, Vesper J, Braun C, Meixensberger J, Ketter R, Mayer-Steinacker R, Reifenberger G, Weller M (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13:707\u2013715","journal-title":"Lancet Oncol"},{"key":"1810_CR106","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/WCO.0000000000000144","volume":"27","author":"A Woehrer","year":"2014","unstructured":"Woehrer A, Bauchet L, Barnholtz-Sloan JS (2014) Glioblastoma survival: has it improved? Evidence from population-based studies. Curr Opin Neurol 27:666\u2013674","journal-title":"Curr Opin Neurol"},{"key":"1810_CR107","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/1534735408330714","volume":"8","author":"ZP Wu","year":"2009","unstructured":"Wu ZP, Gao CW, Wu YG, Zhu QS, Yan C, Xin L, Chuen L (2009) Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model. Integr Cancer Ther 8:88\u201392","journal-title":"Integr Cancer Ther"},{"key":"1810_CR108","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/07357907.2013.861474","volume":"32","author":"LJ Yang","year":"2014","unstructured":"Yang LJ, Zhou CF, Lin ZX (2014a) Temozolomide and radiotherapy for newly diagnosed glioblastoma multiforme: a systematic review. Cancer Invest 32:31\u201336","journal-title":"Cancer Invest"},{"key":"1810_CR109","doi-asserted-by":"publisher","first-page":"8405","DOI":"10.7314\/APJCP.2014.15.19.8405","volume":"15","author":"WB Yang","year":"2014","unstructured":"Yang WB, Xing BZ, Liang H (2014b) Comprehensive analysis of temozolomide treatment for patients with glioma. Asian Pac J Cancer Prev 15:8405\u20138408","journal-title":"Asian Pac J Cancer Prev"},{"key":"1810_CR110","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3109\/15376516.2011.623331","volume":"22","author":"W Yusof","year":"2012","unstructured":"Yusof W, Hua GS (2012) Gene, ethnic and gender influences predisposition of adverse drug reactions to artesunate among Malaysians. Toxicol Mech Methods 22:184\u2013192","journal-title":"Toxicol Mech Methods"},{"key":"1810_CR111","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/neuonc\/nos090","volume":"14","author":"N Zamani","year":"2012","unstructured":"Zamani N, Mohammad Alizadeh A (2012) Drug-induced cholestatic hepatitis: how late can it occur even after the cessation of the culpable drug? Neuro Oncol 14:830","journal-title":"Neuro Oncol"},{"key":"1810_CR112","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1158\/1078-0432.CCR-15-0420","volume":"21","author":"L Zhai","year":"2015","unstructured":"Zhai L, Spranger S, Binder DC, Gritsina G, Lauing KL, Giles FJ, Wainwright DA (2015) Molecular pathways: targeting IDO1 and other tryptophan dioxygenases for cancer immunotherapy. Clin Cancer Res 21:5427\u20135433","journal-title":"Clin Cancer Res"},{"key":"1810_CR113","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3736\/jcim20080206","volume":"6","author":"ZY Zhang","year":"2008","unstructured":"Zhang ZY, Yu SQ, Miao LY, Huang XY, Zhang XP, Zhu YP, Xia XH, Li DQ (2008) Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial. Zhong Xi Yi Jie He Xue Bao 6:134\u2013138","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"1810_CR114","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3892\/ol.2015.3183","volume":"10","author":"ZS Zhang","year":"2015","unstructured":"Zhang ZS, Wang J, Shen YB, Guo CC, Sai KE, Chen FR, Mei X, Han FU, Chen ZP (2015) Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy. Oncol Lett 10:379\u2013383","journal-title":"Oncol Lett"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-016-1810-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-016-1810-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-016-1810-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-016-1810-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T15:33:56Z","timestamp":1659108836000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-016-1810-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,12]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["1810"],"URL":"https:\/\/doi.org\/10.1007\/s00204-016-1810-z","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,12]]},"assertion":[{"value":"24 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}